Skip to: Content | Navigation | Sub Navigation

Experienced Management Team & Clinical Advisory Board

The application of aPDT to chronic sinusitis was first developed by Dr. Merrill Biel, an expert in aPDT and the head of Sinuwave’s Scientific Advisory Board. The Board includes leading academic experts and top clinical practitioners in the field of otolaryngology. Sinuwave’s senior management team consists of executives that each have more than 15 years of relevant development and commercial experience across medical technology, regulatory strategy, bioengineering and related areas. Further, the team has significant start-up and scale-up experience in relevant business models in both private and public company settings.

Carolyn Cross – Chairman & Chief Executive Officer

Ms. Cross was one of the initial founders and financial supporters of Ondine Biomedical Inc. in 1999 and currently serves as the Chairman of the board and Chief Executive Officer of the Company. Ms. Cross has over 18 years direct experience working with early stage companies and has 25 years of experience with public market securities. She sits on a number of Boards including the Board of the International Photodynamic Association (IPA) serving as Treasurer and the Board of the Canadian Foundation of Innovation (appointed by the Prime Minister) serving also on the Audit Committee.

Nicolas Loebel Ph.D. – President & CTO

Dr. Loebel is responsible for leading product research and development, developing the required photochemistry, integration of all systems, pipeline development and building out Sinuwave’s cross-functional teams. He has experience in dental and medical product development and manufacturing, corporate management and business development in both public and private market environments.

Vipul Shah – VP, Finance

Mr. Shah has an extensive financial and accounting background over a span of 30 years and has held senior management positions with a wide range of companies – from biotech & technology start-up to major financial institution and venture capital companies. Mr. Shah obtained his MBA and MPAcc from the Foster School of Business at the University of Washington and has his CPA designation.

Roger Andersen, MD, MPH – VP, Regulatory & Clinical Affairs

Dr. Andersen practiced as a physician & surgeon in Seattle and directed a clinical research organization for pharmaceutical and medical device clinical trials. Prior to joining Sinuwave, Dr. Andersen worked with Ondine Biomedical for the last ten years developing the regulatory and clinical programs. He has worked extensively with the FDA, Health Canada and the EU to obtain regulatory approvals.

Merrill Biel, M.D., Ph.D. – Head, SAB

Dr. Biel is a Professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Minnesota, and a practicing clinician. Dr. Biel has been involved in the preclinical and clinical applications of photodynamic therapy since 1987, and is considered one of the world’s leading experts in the clinical use of photodynamic therapy. He is a founder of Advanced Photodynamic Technologies, which developed the core photodynamic patents for the ENT application prior to its acquisition by Ondine Biomedical Inc. in 2009.